Overview

Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression

Status:
Unknown status
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
Prospective study to evaluate the potential persistent viral effect of raltegravir in 20 treatment experienced HIV patients with incomplete viral suppression
Phase:
N/A
Details
Lead Sponsor:
Hospital Clinic of Barcelona
Treatments:
Raltegravir Potassium